Incorporating Redo-TAVR Feasibility Into Lifelong Aortic Valve Management
Circulation: Cardiovascular Interventions
NOVEMBER 20, 2023
Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013571, November 1, 2023.
Circulation: Cardiovascular Interventions
NOVEMBER 20, 2023
Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013571, November 1, 2023.
Circulation: Cardiovascular Interventions
NOVEMBER 20, 2023
Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013572, November 1, 2023.
Circulation: Cardiovascular Interventions
NOVEMBER 20, 2023
Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013305, November 1, 2023.
Circulation: Cardiovascular Interventions
NOVEMBER 20, 2023
Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e012966, November 1, 2023. Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients.
Circulation: Cardiovascular Interventions
MARCH 17, 2025
Circulation: Cardiovascular Interventions, Volume 18, Issue 3 , Page e014819, March 1, 2025. Patients in shock were excluded. Patients were grouped by the mechanism of mitral regurgitation (MR) and divided into time periods.RESULTS:Overall, 68 028 patients were included.
Circulation: Cardiovascular Interventions
NOVEMBER 6, 2023
Circulation: Cardiovascular Interventions, Ahead of Print. Cox regression was used to evaluate the association between palliation strategy and 6-month mortality.Results:From 2021 to 2023, 17 patients (median age, 4 days; interquartile range [IQR], 2–8; median weight, 2.5 kilograms [IQR, 2.1–3.3])
Circulation: Cardiovascular Interventions
NOVEMBER 9, 2023
Circulation: Cardiovascular Interventions, Ahead of Print. Background:There are limited data about changes in cardiac function (cardiac reverse remodeling) and heart failure indices after transcatheter tricuspid valve-in-valve replacement (TT-VIVR).
Let's personalize your content